Advancing pharmacovigilance through academic–legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis—a research on adverse drug events and reports (RADAR) report

Abstract

This article is the first to demonstrate explicitly the utility of a legal data set to pharmacovigilance research.